Valuation (12%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -13.42 | N/A |
PEG Ratio (TTM) | 43.69 | N/A |
P/S Ratio (TTM) | 12.41 | N/A |
P/B Ratio (TTM) | 44.93 | N/A |
P/FCF Ratio (TTM) | -31.69 | N/A |
Price to 5YR AVG Earnings Ratio | -23.31 | N/A |
Price to 5YR AVG FCF Ratio | -42.33 | N/A |
Profitability (25%) |
Company | Industry |
---|---|---|
ROA (TTM) | -55.38% | N/A |
ROE (TTM) | -234.35% | N/A |
Net Profit Margin (TTM) | -91.87% | N/A |
ROIC 5YR AVG | 56.41% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -5.76% | -47.72% | -37.40% |
Revenue | 16.26% | N/A | 88.16% |
Net Income | -6.35% | -68.11% | -54.37% |
Cash Flow | 12.25% | -53.81% | -38.72% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.44 | N/A |
Quick Ratio (TTM) | 2.37 | N/A |
D/E Ratio (TTM) | 1.94 | N/A |
Interest Coverage (TTM) | -60.75 | N/A |
Piotroski F-Score | 4 | N/A |
Altman Z-Score | 2.16 | N/A |
LTL to 5YR AVG FCF | -1.86 | N/A |
Shares Outstanding Growth 5YR AVG | 11.37% | N/A |